• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ZA7:GR

14.996 EUR 0.276 1.88%

As of 02:25:23 ET on 09/22/2014.

Snapshot for Zafgen Inc (ZA7)

Open: 14.638 Day's Range: 14.638 - 14.996 Volume: 1,555
Previous Close: 14.720 52wk Range: 12.860 - 16.060 1-Yr Rtn: -

Stock Chart for ZA7

No chart data available.
  • ZA7:GR 14.996
  • 1D
  • 1M
  • 1Y
14.720
Interactive ZA7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZA7

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -4.9770
Est. PEG Ratio -
Market Cap (M EUR) 340.51
Shares Outstanding (M) 22.71
30 Day Average Volume 34
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZA7

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZA7

Zafgen Inc. operates as a biopharmaceutical company. The Company develops therapeutics for the treatment of obesity and co-morbidities. Zafgen serves customers worldwide.

Peter BarrettChairmanThomas E HughesChief Executive Officer
Patricia L Allen "Patty"Chief Financial OfficerDennis D KimChief Medical Officer
More Company Profile & Key Executives for ZA7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil